71172
GITR (CD357), Fc fusion (Human) HiP™ Recombinant
BPS Bioscience
DESCRIPTION
Human secreted GITR, Fc fusion protein, also known as Glucocorticoid-induced TNFR-Related Protein, Tumor Necrosis Factor Receptor Superfamily member 18, TNFRSF18, Activation-Inducible TNFR Family Receptor, AITR, and CD357, GenBank Accession No. NM_004195, a.a. 26-161 expressed in a HEK293 cell expression system. MW = 41.2 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation.
DETAILS
- Aa: 26-161
- Mw: 41.2 kDa
- Tags: C-terminal Fc fusion (Human IgG1)
- Notes: The aggregation state of this product has been confirmed to be <10%.
- Format: Aqueous buffer solution
- Genbank: NM_004195
- Species: Human
- Uniprot: Q9Y5U5
- Shiptemp: -80°C (dry ice)
- Synonyms: Glucocorticoid-induced TNFR-Related Protein, Tumor Necrosis Factor Receptor Superfamily member 18, TNFRSF18, Activation-Inducible TNFR Family Receptor, AITR, CD357
- Warnings: Avoid freeze/thaw cycles. Protein may be diluted to ≥100 µg/ml in PBS + glycerol and stored at -80°C.
- Category: Immunotherapy/Protein
- References: 1. Shimizu, J., et al., Nat. Immunol. 2002; 3: 135-142. 2. Ko, K., et al., J. Exp. Med. 2005; 202(7): 885-891.
- Description: Human secreted GITR, Fc fusion protein, also known as Glucocorticoid-induced TNFR-Related Protein, Tumor Necrosis Factor Receptor Superfamily member 18, TNFRSF18, Activation-Inducible TNFR Family Receptor, AITR, and CD357, GenBank Accession No. NM_004195, a.a. 26-161 expressed in a HEK293 cell expression system. MW = 41.2 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation.
- Formulation: 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
- Unspsc Code: 12352202
- Unspsc Name: Proteins
- Applications: Useful for studying protein binding and screening small molecular inhibitors
- Product Type: Protein
- Biosafety Level: Not applicable (BSL-1)
- Endotoxin Level: <1 EU/µg
- Related Products: 71170, 71190
- Storage Stability: At least 6 months at -80°C.
- Scientific Category: Immunotherapy